New breathing training aims to ease symptoms in kidney disease
NCT ID NCT07369973
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding a special breathing feedback device to standard breathing exercises can reduce symptoms and improve quality of life in adults with chronic kidney disease. Twenty-four participants will practice the exercises three times daily for six weeks. The goal is to see if the approach is acceptable and whether it helps with breathing, fatigue, and daily function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- diaphragmatic biofeedback combined with respiratory muscle training
- What this could lead to
- If it works, this could offer a simple, drug-free way to ease breathing problems and improve daily life for people with chronic kidney disease.
- What could go wrong
- This is a very small, early-stage trial (24 people) testing feasibility, not effectiveness. The intervention may not provide meaningful benefits or may be hard to stick with.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGES 4 AND 5) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A softer path for kidney disease: could palliative care ease the burden?
- Can a 30-hour e-learning course equip family doctors to deliver better palliative care?
- Gut health supplement may calm inflammation in kidney dialysis patients
- Thyroid hormones may hold clues to kidney disease progression
- Massive kidney trial aims to revolutionize how we test treatments
- Can a diabetes drug protect dialysis Patients' hearts?